Market News (Page 109) - TendieTensor

Market News Page 109 of 159 • 3,964 articles

Montana Bank Insider Sells $225,000 in Shares Amid Stable Outlook

The Motley Fool • Jonathan Ponciano

Montana Bank Insider Sells $225,000 in Shares Amid Stable Outlook

11/03/2025 09:21 AM • Jonathan Scott, a 10% owner of First Interstate BancSystem, sold 7,000 shares in an open-market transaction valued at $224,630, reducing his indirect holdings to 945,824 shares while maintaining a stable ownership position.

FIBK - The bank shows resilience with steady quarterly performance, a 6% dividend yield, strong capital levels, and disciplined expense control. The insider sale is considered routine and not a significant warning sign.

#insider trading #banking #regional bank #stock sale

What I Wish I Had Known Before Creating My Own Investing Blueprint

The Motley Fool • Reuben Gregg Brewer

What I Wish I Had Known Before Creating My Own Investing Blueprint

11/03/2025 09:18 AM • An experienced investor shares his personal investment journey, highlighting the importance of emotional control, long-term dividend-focused investing, and avoiding impulsive decisions driven by greed or market noise.

NOK - Received $1 billion investment from Nvidia and partnered on next-generation 6G cellular technology
SHW - The author regrets selling Sherwin-Williams stock early and recognizes it as a missed opportunity for significant long-term gains

#dividend investing #long-term strategy #behavioral investing #Warren Buffett #emotional control

Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle

Benzinga • Vandana Singh

Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle

11/03/2025 09:14 AM • Pfizer filed a lawsuit against Metsera and Novo Nordisk in Delaware Court, alleging antitrust violations and breach of contract after Novo Nordisk made an unsolicited $9 billion acquisition proposal that could disrupt Pfizer's planned $4.9 billion acquisition of Metsera.

PFE - Actively pursuing legal action to block a competing acquisition proposal, indicating defensive strategic positioning

#merger #acquisition #antitrust #lawsuit #pharmaceutical

Investing.com • Chris Markoch

3 Safe and Steady Stocks for Any Market

11/03/2025 09:14 AM • In a volatile market, investors are seeking safe, steady stocks with consistent returns and reliable dividends. The article highlights three stocks across consumer staples and real estate sectors that offer stability and potential growth.

KO - Consistently exceeds revenue and earnings expectations, 64 consecutive years of dividend increases, 10% stock price appreciation in 2025, and 2.96% dividend yield

#safe stocks #dividend #market volatility #consumer staples #REIT

Marine Thinking to Become a Publicly Traded Company on NASDAQ via Combination with Eureka Acquisition Corp.

Benzinga • Globe Newswire

Marine Thinking to Become a Publicly Traded Company on NASDAQ via Combination with Eureka Acquisition Corp.

11/03/2025 09:13 AM • Marine Thinking, a physical AI technology company specializing in autonomous ship solutions, will become a publicly traded company by merging with Eureka Acquisition Corp. The transaction values Marine Thinking at approximately $130 million and will list the company on NASDAQ.

FpB - Exceeded revenue expectations, demonstrated strong performance in Ford Pro and Ford Blue segments, reduced tariff headwinds, maintained cost discipline, and showed confidence through dividend yield
EURK - Successfully identifying and merging with an innovative technology company in the marine sector

#marine technology #autonomous ships #SPAC merger #AI navigation #public listing

Ferrari Order Strength and Mastercard Earnings Highlight Premium-Market Resilience

Investing.com • Nathan Reiff

Ferrari Order Strength and Mastercard Earnings Highlight Premium-Market Resilience

11/03/2025 09:12 AM • Ferrari and Mastercard demonstrate strong performance in the premium market, with Ferrari maintaining a robust order book through 2027 and Mastercard beating earnings expectations while expanding into AI and crypto services.

FpC - Exceeded revenue expectations, demonstrated strong performance in Ford Pro and Ford Blue segments, reduced tariff headwinds, maintained cost discipline, and showed confidence through dividend yield
RACE - Strong Q2 financial performance, filled order book through 2027, plans for electric vehicle launch, and overwhelmingly positive analyst ratings (11/12 Buy recommendations)

#luxury brands #digital payments #electric vehicles #premium market #consumer spending

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

GlobeNewswire Inc. • Lyell Immunopharma, Inc.

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

11/03/2025 09:00 AM • Lyell Immunopharma presented clinical trial data for ronde-cel, a dual-targeting CD19/CD20 CAR T-cell therapy for aggressive large B-cell lymphoma, highlighting promising response rates and safety profile at the 67th ASH Annual Meeting.

LYEL - Company presented promising clinical trial data with high response rates, received FDA designations (RMAT and Fast Track), and is advancing development of a novel CAR T-cell therapy with potential differentiated benefits

#CAR T-cell therapy #lymphoma #clinical trial #ASH Annual Meeting #CD19/CD20 targeting

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire Inc. • Nurix Therapeutics

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

11/03/2025 09:00 AM • Nurix Therapeutics will present updated clinical data on bexobrutideg, a novel BTK degrader, at the ASH Annual Meeting, showcasing results in chronic lymphocytic leukemia and Waldenström macroglobulinemia treatments.

NRIX - Company is presenting promising clinical trial data for its investigational drug bexobrutideg across multiple cancer types, indicating potential therapeutic advancements

#BTK #protein degradation #oncology #clinical trials #leukemia

IPSIPAY to launch next-generation Crypto Payment Platform

GlobeNewswire Inc. • William D. Corbett

IPSIPAY to launch next-generation Crypto Payment Platform

11/03/2025 09:00 AM • Innovative Payment Solutions, Inc. launched a new Crypto Payment Platform enabling cryptocurrency transactions for online gaming and sportsbook sectors, supporting multiple digital assets with real-time conversion and compliance features.

UNH - Mentioned in context of Dhivya Suryadevara's previous executive role
IPSI - Company is expanding into digital assets, launching innovative payment platform, and positioning itself for growth in emerging financial technologies

#cryptocurrency #digital payments #fintech #online gaming #blockchain

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire Inc. • Cogent Biosciences

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

11/03/2025 09:00 AM • Cogent Biosciences will present data on bezuclastinib for NonAdvanced Systemic Mastocytosis at the ASH annual meeting, highlighting potential disease modification and introducing a new JAK2 V617F mutant-selective inhibitor program.

GPN - Mentioned in context of CFO Paul Todd's previous role
COGT - Company is showcasing promising clinical trial results, announcing new research programs, and expressing confidence in potential breakthrough therapies for systemic mastocytosis and other genetically defined diseases

#bezuclastinib #NonAdvSM #JAK2 #ASH meeting #clinical trials

Nokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to market

GlobeNewswire Inc. • Nokia Press Office

Nokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to market

11/03/2025 09:00 AM • Nokia and Rohde & Schwarz have developed an AI-powered 6G radio receiver that improves network coverage by using machine learning to compensate for signal distortions, potentially reducing deployment costs and accelerating 6G network rollout.

CLOV - Mentioned as part of Fiserv's strategic small business platform development
NOK - Developing innovative AI technology for future 6G networks, demonstrating technological leadership and potential cost-saving solutions

#6G #AI #wireless technology #network infrastructure #machine learning

Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors

GlobeNewswire Inc. • Sonu Shankar

Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors

11/03/2025 09:00 AM • Phosphorus Cybersecurity launched an autonomous xIoT security platform with transparent per-device pricing, offering comprehensive device discovery, risk assessment, and remediation capabilities for enterprises struggling with diverse and unmanaged IoT devices.

SIEGY - Mentioned through a quote from a former Siemens Industrial Networks Specialist, with no direct negative or positive implications

#xIoT #cybersecurity #device management #risk assessment #IoT security

JAKKS Pacific and SEGA of America Renew Global Toy Partnership for Sonic the Hedgehog™ Merchandise

GlobeNewswire Inc. • Globe Newswire

JAKKS Pacific and SEGA of America Renew Global Toy Partnership for Sonic the Hedgehog™ Merchandise

11/03/2025 09:00 AM • JAKKS Pacific has renewed its partnership with SEGA for the Sonic the Hedgehog toy collection, extending the collaboration until 2029. The multi-year deal allows JAKKS to continue designing and producing action figures, playsets, and other merchandise for the popular video game franchise.

FpD - Exceeded revenue expectations, demonstrated strong performance in Ford Pro and Ford Blue segments, reduced tariff headwinds, maintained cost discipline, and showed confidence through dividend yield
JAKK - Renewed partnership demonstrates continued success with SEGA, expanding product lines and maintaining global toy partnership

#Sonic the Hedgehog #toy partnership #licensing #merchandise

S&P 500 Eyes Fresh Highs as AI Momentum and Trade Truce Fuel Risk Appetite

Investing.com • Fiona Cincotta

S&P 500 Eyes Fresh Highs as AI Momentum and Trade Truce Fuel Risk Appetite

11/03/2025 08:48 AM • US stocks are rising, driven by AI optimism and a US-China trade truce, with the S&P 500 posting its sixth straight monthly gain. Semiconductor firms and tech companies are expected to provide insights into AI demand, while market attention focuses on upcoming economic data and earnings reports.

PLTR - Rising pre-market, lifted full-year revenue forecast, strong demand for AI-linked services

#AI #trade truce #earnings #S&P 500 #market sentiment #Federal Reserve

Elevation Capital Advisory Loads Up Principal U.S. Mega-Cap ETF Shares in Q3

The Motley Fool • Lawrence Rothman

Elevation Capital Advisory Loads Up Principal U.S. Mega-Cap ETF Shares in Q3

11/03/2025 08:31 AM • Elevation Capital Advisory initiated a new $8.7 million position in the Principal U.S. Mega-Cap ETF during Q3, representing 3.5% of its reported equity assets. The ETF focuses on tracking large U.S. mega-cap companies with concentrated holdings across technology, financial, and communication sectors.

USMC - ETF has outperformed S&P 500 by 2.6 percentage points, with a 20.7% return over the past year and holdings in successful large-cap companies

#ETF #mega-cap #investment #equity #technology stocks

IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival

Benzinga • Prnewswire

IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival

11/03/2025 08:30 AM • A study published in PLOS One demonstrates that IceCure's Cryoablation System combined with radiation therapy achieved a 92% disease-specific 5-year survival rate for stage I non-small cell lung cancer patients with tumors ≥2 cm.

ICCM - The study showed highly promising results with 92% 5-year disease-specific survival, 74% overall survival rate, and no treatment-related mortality, which significantly validates the company's medical technology and potential market impact

#cryoablation #lung cancer #radiation therapy #medical technology #cancer treatment

SuperCom to Report Third Quarter 2025 Financial Results on November 13, 2025

Benzinga • Prnewswire

SuperCom to Report Third Quarter 2025 Financial Results on November 13, 2025

11/03/2025 08:30 AM • SuperCom, a global provider of secured solutions for e-Government, IoT, and Cybersecurity, will hold a conference call on November 13, 2025, to discuss its third quarter 2025 financial results.

SPCB - The article is a standard financial results announcement without indicating positive or negative performance, presenting a neutral informative tone about the upcoming earnings call

#financial results #conference call #e-Government #IoT #Cybersecurity

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

Benzinga • Prnewswire

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

11/03/2025 08:30 AM • TOYO Co., Ltd has entered a strategic partnership with Voltec Solar, a French photovoltaic panel manufacturer, to supply high-performance, low-carbon solar cells in the European market, marking TOYO's expansion into Europe.

TOYO - Company is expanding into European market, establishing a strategic partnership, and demonstrating commitment to global solar technology innovation

#solar solutions #strategic partnership #low-carbon technology #European market #sustainability

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon

The Motley Fool • Rachel Warren

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon

11/03/2025 08:28 AM • The article highlights two healthcare stocks suitable for long-term investors: Eli Lilly and Intuitive Surgical. Both companies demonstrate strong growth potential, innovative product pipelines, and consistent financial performance in the healthcare sector.

LLY - Strong revenue growth (38% YoY), successful GLP-1 franchise, promising drug pipeline in oncology and neuroscience, consistent dividend history, and strategic manufacturing investments

#healthcare #long-term investing #pharmaceutical #surgical robotics #GLP-1 #medical technology

US Stocks Face Two Short-Term Threats Amid Fed's Cautious Approach, Warn Analysts

Benzinga • Namrata Sen

US Stocks Face Two Short-Term Threats Amid Fed's Cautious Approach, Warn Analysts

11/03/2025 08:27 AM • Morgan Stanley analysts warn of two key risks for US stocks: the Federal Reserve's cautious interest rate policy and potential tariff impacts. Despite strong corporate earnings, market uncertainty remains about future monetary stance.

QQQ - Year-to-date performance is strong (+23.29%), but analysts caution about potential market challenges

#Federal Reserve #interest rates #stock market #corporate earnings #tariffs

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

Benzinga • Prnewswire

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

11/03/2025 08:25 AM • NewcelX, a Swiss clinical-stage biopharmaceutical company, announced a strategic roadmap update after merging with NLS Pharmaceutics Ltd., focusing on developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

NCEL - Company provided a strategic update and investor presentation, indicating ongoing development of therapeutic platforms without explicitly positive or negative financial indicators

#biotechnology #neurodegenerative diseases #metabolic diseases #clinical trials #stem-cell technologies

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)

Benzinga • Rishabh Mishra

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)

11/03/2025 08:22 AM • U.S. stock futures advanced on Monday following strong October gains, with markets anticipating potential Federal Reserve interest rate cuts and focusing on upcoming earnings reports from several key companies.

MU - Jumped 4.32% in premarket, supported by upbeat memory chip forecast and maintained strong price trends across short, medium, and long terms

#stock market #futures #earnings #Federal Reserve #interest rates

This Dirt Cheap AI Stock Just Announced Its First-Ever Dividend

The Motley Fool • Matt Frankel

This Dirt Cheap AI Stock Just Announced Its First-Ever Dividend

11/03/2025 08:11 AM • PayPal announced its first dividend and highlighted strong AI partnerships with Google and OpenAI, demonstrating potential growth in the fintech and AI sectors with impressive Q3 financial results.

PYPL - Strong Q3 financial performance, new dividend program, strategic AI partnerships, low valuation, and potential for future earnings growth

#PayPal #AI #dividend #fintech #OpenAI #Google

These 2 AI ETFs Are Ready to Crush the S&P 500 Over the Next 10 Years

The Motley Fool • Matt Frankel

These 2 AI ETFs Are Ready to Crush the S&P 500 Over the Next 10 Years

11/03/2025 08:08 AM • The article discusses two AI-focused ETFs that offer different investment strategies: the Invesco QQQ ETF, which provides broad AI exposure through large-cap tech stocks, and the Ark Autonomous Technology & Robotics ETF, which focuses on unique AI and robotics opportunities with an actively managed approach.

QQQ - Low expense ratio (0.20%), broad exposure to top AI companies, represents over 56% of assets in top 10 holdings

#AI #ETF #technology #investing #robotics

Am I the Only One Worried That Apple Hasn't Earned Its Recent Upticks?

The Motley Fool • Rick Munarriz

Am I the Only One Worried That Apple Hasn't Earned Its Recent Upticks?

11/03/2025 08:07 AM • Apple's stock has risen 64% since April, but the company's revenue growth remains slow, with concerns about innovation and sustained growth potential despite hitting new intraday highs.

AAPL - Slow revenue growth (1.8% CAGR over three years), lack of innovation, trading at 33x forward earnings with minimal growth prospects, and potential stagnation after potential short-term growth

#Apple #stock performance #revenue growth #innovation #iPhone #tech stocks